Axsome Therapeutics (AXSM) Earnings Date, Estimates & Call Transcripts → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free AXSM Stock Alerts $73.47 +0.97 (+1.34%) (As of 10:10 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 5EstimatedActual EPS (Feb. 20) -$0.73 Beat By $0.48 Consensus EPS (Feb. 20) -$1.21 Get Axsome Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for AXSM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAXSM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AXSM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit Axsome Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244($1.33)($1.26)($1.30) Q2 20244($1.46)($1.18)($1.33) Q3 20244($1.35)($0.99)($1.18) Q4 20244($1.35)($0.87)($1.04) FY 202416($5.49)($4.30)($4.84) Q1 20253($0.96)($0.88)($0.93) Q2 20253($0.53)($0.39)($0.44) Q3 20253($0.04)$0.47$0.16 Q4 20253$0.45$1.33$0.78 FY 202512($1.08)$0.53 ($0.42)AXSM Earnings Date and InformationAxsome Therapeutics last issued its quarterly earnings results on February 20th, 2024. The reported ($0.73) earnings per share for the quarter, beating analysts' consensus estimates of ($1.21) by $0.48. The business earned $71.53 million during the quarter, compared to analyst estimates of $70.38 million. Axsome Therapeutics has generated ($6.38) earnings per share over the last year (($6.38) diluted earnings per share). Axsome Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off prior year's report dates.Read More Axsome Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/5/2024Estimated)------- 2/20/2024Q4 2023($1.21)($0.73)+$0.48$0.62$70.38 million$71.53 million11/6/2023Q3 2023($1.24)($1.32)($0.08)($1.32)$54.88 million$57.79 million 8/7/2023Q2 2023($1.24)($1.00)+$0.24($0.46)$40.19 million$46.70 million5/8/2023Q1 2023($1.13)($0.22)+$0.91($0.18)$26.87 million$94.58 million2/27/2023Q4 2022($1.18)($1.28)($0.10)($1.15)$21.51 million$24.37 million 11/7/2022Q3 2022($1.10)($1.03)+$0.07($0.99)$16.59 million$16.85 million Get the Latest News and Ratings for AXSM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Axsome Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022($1.19)($1.06)+$0.13($1.06)$9.59 million$8.82 million 5/2/2022Q1 2022($1.02)($1.03)($0.01)($1.03)-- 3/1/2022Q4 2021($0.99)($0.90)+$0.09($0.90)-- 11/8/2021Q3 2021($0.95)($0.93)+$0.02($0.93)-- 8/8/2021Q2 2021($0.88)($0.86)+$0.02($0.86)-- Axsome Therapeutics Earnings - Frequently Asked Questions When is Axsome Therapeutics's earnings date? Axsome Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates. Learn more on AXSM's earnings history. Did Axsome Therapeutics beat their earnings estimates last quarter? In the previous quarter, Axsome Therapeutics (NASDAQ:AXSM) reported ($0.73) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.21) by $0.48. Learn more on analysts' earnings estimate vs. AXSM's actual earnings. How much revenue does Axsome Therapeutics generate each year? Axsome Therapeutics (NASDAQ:AXSM) has a recorded annual revenue of $270.60 million. How much profit does Axsome Therapeutics generate each year? Axsome Therapeutics (NASDAQ:AXSM) has a recorded net income of -$239.24 million. AXSM has generated -$6.38 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Biohaven Earnings Date Summit Therapeutics Earnings Date Crinetics Pharmaceuticals Earnings Date Ultragenyx Pharmaceutical Earnings Date Prestige Consumer Healthcare Earnings Date Insmed Earnings Date Xenon Pharmaceuticals Earnings Date Alkermes Earnings Date Perrigo Earnings Date IDEAYA Biosciences Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:AXSM) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThis 1 Biotech Stock has been shocking the marketsHuge AlertsNext President (Not Trump. Not Biden.)The Freeport SocietyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axsome Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.